Eva Wardelmann

22.6k total citations · 3 hit papers
292 papers, 10.5k citations indexed

About

Eva Wardelmann is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Oncology. According to data from OpenAlex, Eva Wardelmann has authored 292 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Pulmonary and Respiratory Medicine, 95 papers in Gastroenterology and 82 papers in Oncology. Recurrent topics in Eva Wardelmann's work include Sarcoma Diagnosis and Treatment (105 papers), Gastrointestinal Tumor Research and Treatment (95 papers) and Gastric Cancer Management and Outcomes (46 papers). Eva Wardelmann is often cited by papers focused on Sarcoma Diagnosis and Treatment (105 papers), Gastrointestinal Tumor Research and Treatment (95 papers) and Gastric Cancer Management and Outcomes (46 papers). Eva Wardelmann collaborates with scholars based in Germany, United States and Sweden. Eva Wardelmann's co-authors include Christiane Kühl, C Leutner, Hans H. Schild, Sabine Merkelbach‐Bruse, Peter Hohenberger, Walther Kuhn, Simone Schrading, Sven Klaschik, Hans‐Ulrich Schildhaus and Reinhard Büttner and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eva Wardelmann

279 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamic Breast MR Imaging: Are Signal Intensity Time Course Data Useful for Differential Diagnosis of Enhancing Lesions?

1999 1.0k citations Christiane Kühl, Sven Klaschik et al. profile →
Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer

2005 824 citations Christiane Kühl, Eva Wardelmann et al. Journal of Clinical Oncology profile →
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study

2007 488 citations Christiane Kühl, Eva Wardelmann et al. profile →

Peers

Countries citing papers authored by Eva Wardelmann

Since Specialization

Citations

This map shows the geographic impact of Eva Wardelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Wardelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Wardelmann more than expected).

Fields of papers citing papers by Eva Wardelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Wardelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Wardelmann. The network helps show where Eva Wardelmann may publish in the future.

Co-authorship network of co-authors of Eva Wardelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Wardelmann. A scholar is included among the top collaborators of Eva Wardelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Wardelmann. Eva Wardelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience 2024 ·Surgery ·(unknown), (unknown), Dhruvajyoti Roy, (unknown), (unknown), (unknown), Emile Rijcken, (unknown), Peter Barth, Eva Wardelmann, Andreas Pascher, Mazen A. Juratli	5
2	PD‐L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD‐L1‐low and ‐negative patients with non‐small cell lung cancer 2024 ·Journal of Extracellular Vesicles ·(unknown), (unknown), Kerstin Menck, Georg Evers, (unknown), Arik Bernard Schulze, Georg Lenz, Eva Wardelmann, Claudia R. Binder, Annalen Bleckmann	13
3	Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma 2024 ·Clinical Cancer Research ·(unknown), Kwang Seok Lee, (unknown), (unknown), (unknown), (unknown), Susanne Häfner, Bianca Altvater, Claudia Rössig, Pierre Åman, Eva Wardelmann, Claudia Scholl, Wolfgang Hartmann, Stefan Fröhling, Marcel Trautmann	1
4	Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma 2023 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), Eva Wardelmann, Olle Larsson, Marcel Trautmann, Wolfgang Hartmann	3
5	A Systematic Review and Illustrative Case Presentation of Low-Grade Myofibroblastic Sarcoma (LGMS) of the Extremities 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Burkhard Lehner, Gunhild Mechtersheimer, Eva Wardelmann, Rosa Klotz, Eva Kalkum, Marcus Schiltenwolf, Leila Harhaus, Tobias Renkawitz, Benjamin Panzram	2
6	Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas 2021 ·European Journal of Cancer ·(unknown), Saskia Litière, Anouk Neven, (unknown), Ian Judson, Patrick Schöffski, Eva Wardelmann, Silvia Stacchiotti, Lorenzo D’Ambrosio, Sandrine Marréaud, Winette T.A. van der Graaf, Bernd Kasper, Marta Fiocco, Hans Gelderblom	7
7	κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis 2020 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sankar Ghosh, Eva Wardelmann, Michael Meisterernst, Konrad Steinestel, Andrea Oeckinghaus	26
8	Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma 2019 ·Molecular Cancer Therapeutics ·Marcel Trautmann, (unknown), (unknown), (unknown), Arne Krüger, Inga Grünewald, Konrad Steinestel, Bianca Altvater, Claudia Rössig, Susanne Häfner, Thomas Simmet, Jessica Becker, Pierre Åman, Eva Wardelmann, Sebastian Huss, Wolfgang Hartmann	28
9	SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma 2019 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), Sareetha Kailayangiri, Bianca Altvater, Claudia Rössig, Konrad Steinestel, Inga Grünewald, Sebastian Huss, Eva Eßeling, Jan‐Henrik Mikesch, Susanne Häfner, Thomas Simmet, Agnieszka Woźniak, Patrick Schöffski, Olle Larsson, Eva Wardelmann, Marcel Trautmann, Wolfgang Hartmann	38
10	Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth 2018 ·PLoS ONE ·Nicole Bäumer, (unknown), (unknown), (unknown), Wolfgang Hartmann, Eva Wardelmann, Frank Buchholz, Carsten Müller‐Tidow, Wolfgang E. Berdel, Sebastian Bäumer	4
11	Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment 2018 ·PLoS ONE ·Michaela A. Ihle, Sebastian Huss, (unknown), Wolfgang Hartmann, Sabine Merkelbach‐Bruse, Hans‐Ulrich Schildhaus, Reinhard Büttner, Harri Sihto, Kirsten Sundby Hall, Mikael Eriksson, Peter Reichardt, Heikki Joensuu, Eva Wardelmann	18
12	FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma 2017 ·Clinical Cancer Research ·Marcel Trautmann, (unknown), (unknown), (unknown), (unknown), Konrad Steinestel, (unknown), Inga Grünewald, Bianca Altvater, Claudia Rössig, Stefan Fröhling, Susanne Häfner, Thomas Simmet, Pierre Åman, Eva Wardelmann, Sebastian Huss, Wolfgang Hartmann	38
13	Prognostic relevance of epithelial–mesenchymal transition and proliferation in surgically treated primary parotid gland cancer 2016 ·Journal of Clinical Pathology ·(unknown), (unknown), Eva Wardelmann, Claudia Rudack, Inga Grünewald, Markus Stenner	8
14	Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma 2016 ·Clinical Cancer Research ·Manuela Krumbholz, (unknown), (unknown), Tobias Bäuerle, (unknown), (unknown), Abbas Agaimy, Benjamin Frey, (unknown), Eva Wardelmann, Wolfgang Hartmann, Heribert Juergens, Uta Dirksen, Markus Metzler	61
15	Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial 2015 ·Journal of Clinical Oncology ·Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Jörg T. Hartmann, Daniel Pink, Giuliano Ramadori, Peter Hohenberger, Salah‐Eddin Al‐Batran, M. Schlemmer, Sebastian Bauer, Eva Wardelmann, Bengt Nilsson, Harri Sihto, Petri Bono, Raija Kallio, Jouni Junnila, Thor Alvegård, Peter Reichardt	149
16	Antibody-Mediated Delivery of Anti– KRAS -siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer 2015 ·Clinical Cancer Research ·Sebastian Bäumer, Nicole Bäumer, (unknown), (unknown), (unknown), Sonja Schelhaas, Eva Wardelmann, Frank Buchholz, Wolfgang E. Berdel, Carsten Müller‐Tidow	92
17	Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST 2014 ·Clinical Cancer Research ·Agnieszka Woźniak, Piotr Rutkowski, Patrick Schöffski, Isabelle Ray‐Coquard, Isabelle Hostein, Hans‐Ulrich Schildhaus, Axel Le Cesne, Elżbieta Bylina, Janusz Limon, Jean‐Yves Blay, Janusz A. Siedlecki, Eva Wardelmann, Raf Sciot, Jean‐Michel Coindre, Maria Dêbiec‐Rychter	121
18	Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1 2008 ·Clinical Cancer Research ·Chiara Mussi, Hans‐Ulrich Schildhaus, Alessandro Gronchi, Eva Wardelmann, Peter Hohenberger	123
19	Sustained Platelet-Derived Growth Factor Receptor α Signaling in Osteoblasts Results in Craniosynostosis by Overactivating the Phospholipase C-γ Pathway 2008 ·Molecular and Cellular Biology ·(unknown), Richard Jäger, Angela Egert, Wolfram Kreß, Eva Wardelmann, Hubert Schorle	38
20	Do T2‐weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI? 1999 ·Journal of Magnetic Resonance Imaging ·Christiane Kühl, Sven Klaschik, (unknown), Jürgen Gieseke, Eva Wardelmann, Hans H. Schild	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact